Research map: Efficacy and safety of lipid-lowering therapy in liver transplant recipients (the PINTL study): cohort design and baseline characteristics

Back to the article

Papers in this map

  1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk · François Mach · 2019 · 9168 citations · Cited by this paper
  2. Assessment of municipal infrastructure related to population lifestyle in the Pskov region · 2026 · Related
  3. Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011) · Pierre‐Jean Touboul · 2012 · 1831 citations · Cited by this paper
  4. II International Congress "Therapy and Preventive Medicine". Collection of abstracts · 2026 · Related
  5. EASL Clinical Practice Guidelines: Liver transplantation · 2015 · 1086 citations · Cited by this paper
  6. Effectiveness of a neural network-based fatal event prediction using conventional risk factors based on thirty-year prospective follow-up · 2026 · Related
  7. Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study · K.D.S. Watt · 2010 · 792 citations · Cited by this paper
  8. Chronic coronary artery disease as a cause of death: analysis of medical certificates of cause of death from several regions of the Russian Federation · 2026 · Related
  9. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association · Barbara S. Wiggins · 2016 · 338 citations · Cited by this paper
  10. Impact of blood electrolyte parameters on the incidence of paroxysmal atrial fibrillation in patients with chronic kidney disease with and without albuminuria · 2026 · Related
  11. Cumulative Risk of Cardiovascular Events After Orthotopic Liver Transplantation · Mazen Albeldawi · 2011 · 197 citations · Cited by this paper
  12. Cardiac-renal-hepatic-metabolic disease in chronic heart failure (CARMEN-CHF): rationale and design of an observational multicenter prospective study · 2026 · Related
  13. Cyclosporine A, but Not Tacrolimus, Shows Relevant Inhibition of Organic Anion-Transporting Protein 1B1-Mediated Transport of Atorvastatin · Rune Amundsen · 2010 · 135 citations · Cited by this paper
  14. Optimization of the diagnosis of cardiovascular adverse events in patients with non-Hodgkin lymphomas · 2026 · Related
  15. Correction to: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines · 2023 · 121 citations · Cited by this paper
  16. Structural and functional state of upper limb skin microvessels of healthy normotensive working-age individuals depending on body mass index and metabolic status · 2026 · Related
  17. Post-transplant dyslipidemia: Mechanisms, diagnosis and management · Arnav Agarwal · 2016 · 120 citations · Cited by this paper
  18. Effective strategies for developing professional written communication in medical students · 2026 · Related
  19. Pharmacokinetics interactions of monoclonal antibodies · Nicola Ferri · 2016 · 109 citations · Cited by this paper
  20. A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status · Michael Ronan Lucey · 2005 · 91 citations · Cited by this paper
  21. Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years · Anoop Ninan Koshy · 2020 · 82 citations · Cited by this paper
  22. Management of dyslipidemia in adult solid organ transplant recipients · Bruce A. Warden · 2019 · 72 citations · Cited by this paper
  23. Lipids in liver transplant recipients · Anna Hüsing · 2016 · 52 citations · Cited by this paper
  24. Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions · Daniel R. Migliozzi · 2019 · 43 citations · Cited by this paper
  25. Focused vascular ultrasound. Consensus of Russian experts · Tat'yana Valentinovna Balakhonova · 2022 · 25 citations · Cited by this paper
  26. Evaluation and management of abnormal liver enzymes in the liver transplant recipient: When, why, and what now? · Emily Rose Harding-Theobald · 2023 · 10 citations · Cited by this paper
  27. AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and post-transplant management of non-graft–related complications · Pratima Sharma · 2025 · 9 citations · Cited by this paper
  28. Long‐Term Outcomes of Liver Transplant Recipients. What Do Patients Die From? · Carlos Jiménez Romero · 2025 · 7 citations · Cited by this paper
  29. Coronary Atherosclerosis in Liver Transplant Recipients and Population Controls · Andreas Dehlbæk Knudsen · 2026 · 7 citations · Cited by this paper
  30. Identification of Genetic Variants Associated with Pravastatin and Pitavastatin Pharmacokinetics · Anssi J. H. Mykkänen · 2025 · 6 citations · Cited by this paper
  31. Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a network meta-analysis · Bohan Luo · 2025 · 3 citations · Cited by this paper
  32. Cardiometabolic profile and characteristics of lipid-lowering therapy in liver transplant recipients in the practice of a cardiologist · А. А. Кучеров · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)